Sea Buckthorn

*Hippophae rhamnoides*

Evidence Rating

D Fair

Confidence Level

Low

Traditions

Western TCM

Last Updated

2/21/2026

Summary

Sea buckthorn is a thorny shrub native to Europe and Asia whose berries and seeds yield oils with a distinctive nutritional profile, notably rich in the rare omega-7 fatty acid (palmitoleic acid), along with vitamins C and E, carotenoids, flavonoids, and phytosterols. Used in both Traditional Chinese Medicine (Sha Ji) and European folk medicine, it has a long history for skin conditions, wound healing, and mucosal health. Clinical trials show benefits for skin hydration, elasticity, and epithelial integrity, with a notable RCT demonstrating improved vaginal epithelial integrity in postmenopausal women (though effects on vaginal dryness symptoms themselves were not significant). The oil contains over 190 bioactive compounds. No Commission E, ESCOP, or EMA monograph exists. Current evidence is preliminary but growing, with the unique omega-7 content and broad bioactive profile supporting continued investigation for dermatological and mucosal applications.

Regulatory Status

Regulatory BodyStatus
Commission E (Germany)
ESCOP (European)
EMA/HMPC (EU)

Metadata

FieldDetail
Common Names (English)Sea Buckthorn, Seaberry
Common Names (German/Chinese)Sanddorn / Sha Ji (沙棘)
Botanical NameHippophae rhamnoides L. (syn. Elaeagnus rhamnoides)
Plant FamilyElaeagnaceae (Oleaster family)
Part UsedBerry pulp oil, seed oil, whole fruit; leaves used in some traditional preparations
Key ConstituentsFatty acids: palmitoleic acid (omega-7, 16-40% of pulp oil), palmitic acid, oleic acid, linoleic acid, alpha-linolenic acid; vitamins: C (very high, 200-2500 mg/100g), E (tocopherols and tocotrienols), A (as carotenoids); flavonoids: isorhamnetin, quercetin, kaempferol glycosides; carotenoids: beta-carotene, lycopene, zeaxanthin; phytosterols: beta-sitosterol, stigmasterol
Major Standardized ExtractsPulp oil (omega-7-rich), seed oil (omega-3/6-rich); supercritical CO2 extracts; no single dominant standardized product
Evidence Quality RatingPreliminary — growing clinical evidence for skin and mucosal health; no regulatory monographs

Approved Indications

Commission E (Germany)

  • No Commission E monograph has been published for Hippophae rhamnoides

ESCOP

  • No ESCOP monograph has been published for Hippophae rhamnoides

EMA/HMPC (European Medicines Agency)

  • No EMA/HMPC monograph has been published for Hippophae rhamnoides

Agreement/Disagreement Between Bodies

  • No regulatory approval: None of the major European herbal regulatory bodies have published a monograph for sea buckthorn
  • Notable: Sea buckthorn is increasingly recognized in nutritional and cosmeceutical research, but the absence of formal regulatory assessment reflects the relatively recent emergence of clinical evidence
  • TCM context: Sea buckthorn (Sha Ji) has official pharmacopoeial status in the Chinese Pharmacopoeia and is used in TCM for promoting blood circulation, removing blood stasis, and treating cough with phlegm
  • Russian/Central Asian tradition: Extensively used and researched in Russia, Mongolia, and Central Asian countries, with a strong tradition of use for burns, wounds, and radiation injury

Conditions Treated

Primary (Moderate Evidence)

  • Skin health and hydration: Clinical studies show improvements in skin moisture, elasticity, and overall appearance with oral sea buckthorn oil supplementation
  • Mucosal epithelial integrity: An RCT in postmenopausal women showed improved vaginal epithelial integrity with oral sea buckthorn oil (3 g/day)

Secondary (Limited Evidence)

  • Wound healing: Traditional use and preclinical evidence for accelerated wound healing; topical application enhances collagen synthesis and tissue repair
  • Atopic dermatitis: Preliminary evidence for symptom improvement through oral supplementation with seed oil
  • Dry eye syndrome: Emerging evidence for improvement with oral sea buckthorn oil supplementation
  • Vaginal atrophy (postmenopausal): Improved epithelial integrity demonstrated, though subjective symptom improvement was not statistically significant

Traditional/Historical (Limited Evidence)

  • Burns and radiation injury (Russian medical tradition; used clinically for burns in Soviet/Russian hospitals)
  • Gastric ulcers and GI mucosal protection (TCM and Russian tradition)
  • Cough with phlegm (TCM indication; Sha Ji is classified as a cough suppressant and expectorant)
  • Cardiovascular protection (preliminary evidence for lipid modulation)
  • Liver protection (preclinical data)
  • UV skin protection (topical traditional use)

Mechanism of Action

Primary Mechanisms

Skin Barrier and Mucosal Protection (Omega-7):

  • Palmitoleic acid (omega-7) is a major component of human skin and mucosal epithelial tissue, making sea buckthorn pulp oil uniquely relevant to skin and mucosal health
  • Oral supplementation with omega-7-rich oil may support the structural integrity of epithelial membranes by providing building blocks for membrane phospholipids
  • Palmitoleic acid also has anti-inflammatory properties, reducing NF-kB pathway activation in skin cells

Wound Healing:

  • Sea buckthorn oil promotes collagen synthesis and fibroblast proliferation at wound sites
  • The combination of vitamin C (essential cofactor for collagen synthesis), vitamin E (antioxidant protection), and carotenoids (antioxidant, anti-inflammatory) provides synergistic support for tissue repair
  • Beta-sitosterol contributes anti-inflammatory effects that may reduce excessive inflammation during wound healing

Anti-inflammatory and Antioxidant:

  • Flavonoids (isorhamnetin, quercetin) provide potent antioxidant and anti-inflammatory activity
  • Carotenoids (beta-carotene, lycopene, zeaxanthin) scavenge reactive oxygen species and protect against oxidative damage to tissues
  • The combined antioxidant capacity of sea buckthorn is among the highest of any fruit

Secondary Mechanisms

CompoundActivity
Palmitoleic acid (omega-7)Epithelial membrane support, anti-inflammatory (NF-kB inhibition), insulin sensitizing (preclinical)
IsorhamnetinAntioxidant, anti-inflammatory, anti-cancer (preclinical); the most abundant flavonoid in sea buckthorn
QuercetinAntioxidant, anti-inflammatory, capillary-protective
Beta-carotene / CarotenoidsProvitamin A, antioxidant, photoprotective, immunomodulatory
Vitamin CCollagen synthesis cofactor, antioxidant, immune support; sea buckthorn berries contain 5-10 times more vitamin C than oranges
Vitamin E (tocopherols)Lipophilic antioxidant, membrane stabilizer, anti-inflammatory
Beta-sitosterolAnti-inflammatory, cholesterol-lowering (preclinical), wound healing promotion
Linoleic/Alpha-linolenic acids (seed oil)Essential fatty acids; skin barrier function; anti-inflammatory through prostaglandin modulation

Two Distinct Oils

  • Pulp/berry oil: Rich in palmitoleic acid (omega-7, 16-40%), palmitic acid, and carotenoids; deep orange color; unique fatty acid profile
  • Seed oil: Rich in linoleic acid (omega-6) and alpha-linolenic acid (omega-3) in approximately equal proportions; lighter in color; more typical plant oil profile
  • These two oils have different compositions and may have different clinical applications

Clinical Evidence Summary

Volume of Evidence

  • Growing but still limited. Several RCTs have been published for dermatological and mucosal applications, but most are small. No comprehensive systematic review integrating all clinical evidence has been published.

Key Studies

Vaginal Atrophy and Mucosal Health

StudyDesignNKey Finding
Larmo et al. 2014RCT, DB, PC1163 g/day sea buckthorn oil for 3 months in postmenopausal women with vaginal dryness: significantly improved vaginal epithelial integrity vs placebo; however, no significant improvement in vaginal pH, maturation index, elasticity, fluid volume, moisture, or subjective symptoms of dryness/burning/itching

Skin Health

StudyDesignNKey Finding
Hwang et al. 2012RCT, DB, PC49Oral sea buckthorn pulp oil improved skin moisture and elasticity after 8 weeks of supplementation
Jaroszewska et al. 2022ObservationalVariousTopical sea buckthorn oil improved wound healing and skin hydration in clinical settings

Atopic Dermatitis

StudyDesignNKey Finding
Yang et al. 1999RCT, DB49Oral sea buckthorn seed oil (5 g/day for 4 months) showed trends toward improvement in atopic dermatitis symptoms, though differences were not statistically significant

Dry Eye

StudyDesignNKey Finding
Larmo et al. 2010RCT, DB, PC862 g/day sea buckthorn oil for 3 months reduced redness and burning of eyes during the cold season, but did not significantly affect tear film osmolarity or Schirmer’s test

Evidence Gaps

  • No European regulatory assessment
  • Most studies are small (N < 120) and of short duration (2-4 months)
  • Inconsistency in the type of oil used across studies (pulp oil vs seed oil vs blends)
  • Lack of standardization of omega-7 content in clinical trial preparations
  • Limited data on dose-response relationships
  • No large-scale or long-term safety studies
  • The distinction between pulp oil and seed oil effects is poorly characterized in clinical studies

European vs US/Anglophone Consensus

AspectEuropean ConsensusUS/Anglophone Consensus
Regulatory statusNo formal regulatory monograph; recognized in Russian and Chinese pharmacopoeias but not in EU regulatory frameworks; available as food supplementDietary supplement; widely marketed for skin health and as an omega-7 source; no FDA therapeutic claims
Medicinal useGrowing interest in dermatological and nutritional applications; significant research base in Northern Europe (Finland, Germany); long tradition in Russia and Central AsiaNiche but growing market for skin health supplements; omega-7 supplements increasingly popular
Traditional contextEuropean folk medicine tradition in Nordic and Eastern European countries; extensively used in Russian clinical medicine for burnsTCM tradition recognized; Russian clinical use for burns and radiation injury acknowledged in integrative medicine
Research interestActive research in Nordic countries (Finland especially) and Germany; cosmeceutical applications being exploredGrowing research interest, particularly for dry eye and women’s health applications
Nutritional recognitionRecognized as a nutrient-dense berry; juice and oil products available in health food storesGrowing recognition as a “superfruit”; omega-7 content as a unique selling point

Safety Profile

Contraindications

  • Known hypersensitivity to Hippophae rhamnoides or Elaeagnaceae plants
  • Caution in individuals with bleeding disorders (see drug interactions)

Drug Interactions

  • Anticoagulants/Antiplatelet drugs (warfarin, aspirin, clopidogrel): Sea buckthorn oil has been reported to inhibit platelet aggregation in preclinical studies; theoretical additive anticoagulant effect. Clinical significance is not established, but monitoring is advisable
  • Antihypertensive medications: Some preclinical evidence of blood pressure-lowering effects; additive hypotension is theoretically possible
  • Antidiabetic medications: Preliminary evidence of blood sugar-lowering effects; monitor for hypoglycemia
  • No clinically documented serious drug interactions have been reported at standard doses; the interactions listed above are theoretical and based on preclinical data

Side Effects

  • Generally very well tolerated at recommended doses
  • Mild gastrointestinal upset (nausea, diarrhea) at higher doses
  • Loose stools (due to the oil content, particularly at doses above 3 g/day)
  • Orange discoloration of skin (carotenodermia) with very high intake (harmless and reversible)
  • Allergic reactions are rare but possible

Pregnancy/Lactation

  • Pregnancy: Insufficient safety data for medicinal doses. Sea buckthorn is consumed as a food in many cultures during pregnancy without reported adverse effects, but therapeutic doses of concentrated oil have not been studied. Consult a healthcare provider before use
  • Lactation: Insufficient safety data for medicinal doses. Dietary consumption of sea buckthorn berries or juice is likely safe, but concentrated oil supplements have not been studied during breastfeeding
  • Children: No specific contraindication; sea buckthorn juice and berries are consumed as food by children in many countries. However, therapeutic use of concentrated oil preparations in children has not been studied

Clinical Dosage

Standard Dosage Forms

FormPreparationDaily DoseNotes
Pulp/berry oil (capsules)Supercritical CO2 extract or cold-pressed pulp oil1-3 g dailyRich in omega-7 (palmitoleic acid); the form most relevant to skin and mucosal applications
Seed oil (capsules)Cold-pressed seed oil1-3 g dailyRich in omega-3 and omega-6; different fatty acid profile from pulp oil
Combined oil (capsules)Blend of pulp and seed oil2-3 g dailySome products combine both oils; composition varies
Berry juiceFresh or pasteurized juice20-50 mL dailyNutritional use; provides vitamin C, carotenoids, and flavonoids
Topical oilPulp oil or seed oil applied to skinApply to affected area 1-2 times dailyTraditional wound healing and skin care use
Dried berry powderFreeze-dried or air-dried berries5-10 g dailyNutritional supplement form

Clinical Trial Doses

  • Larmo et al. 2014 (vaginal atrophy): 3 g/day sea buckthorn oil (3 capsules twice daily) for 3 months
  • Larmo et al. 2010 (dry eye): 2 g/day sea buckthorn oil for 3 months
  • Yang et al. 1999 (atopic dermatitis): 5 g/day sea buckthorn seed oil for 4 months
  • Typical supplemental range: 1-3 g/day of oil (pulp, seed, or blend) with meals for 8-12 weeks

Duration

  • Clinical trials have typically lasted 2-4 months
  • Effects on skin hydration may become apparent within 4-8 weeks
  • Long-term supplementation appears safe based on food use history, but controlled long-term safety data are limited

Sources

  • Larmo PS, et al. Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women: a randomized, double-blind, placebo-controlled study. Maturitas. 2014;79(3):316-321
  • Larmo PS, et al. Effects of sea buckthorn berries on infections and inflammation: a double-blind, randomized, placebo-controlled trial. Eur J Clin Nutr. 2008;62(9):1123-1130
  • Larmo PS, et al. Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. J Nutr. 2010;140(8):1462-1468
  • Bal LM, et al. Sea buckthorn berries: a potential source of valuable nutrients for nutraceuticals and cosmeceuticals. Food Res Int. 2011;44(7):1718-1727
  • Gao X, et al. Phytochemistry, health benefits, and food applications of sea buckthorn (Hippophae rhamnoides L.): a comprehensive review. Food Chem X. 2022;16:100487
  • Zielinska A, Nowak I. Abundance of active ingredients in sea-buckthorn oil. Lipids Health Dis. 2017;16(1):95
  • Ito H, et al. The impact of sea buckthorn oil fatty acids on human health. Lipids Health Dis. 2019;18(1):145
  • Yang B, et al. Effects of oral supplementation of sea buckthorn seed and pulp oils on the fatty acid composition of skin glycerophospholipids in patients with atopic dermatitis. J Nutr Biochem. 1999;10(6):363-369
  • Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Entry on Sha Ji (Fructus Hippophae)

Connections

  • Compare with Calendula for wound healing applications; calendula has stronger European regulatory support (Commission E, EMA) for topical wound healing but a different mechanism (anti-inflammatory, antimicrobial vs. fatty acid/nutritional)
  • Compare with Aloe Vera for skin health and wound healing; aloe has a much larger evidence base and broader clinical use for dermatological conditions
  • Related to Evening Primrose Oil as a therapeutic fatty acid supplement for skin conditions; evening primrose provides gamma-linolenic acid (omega-6) whereas sea buckthorn provides the unique omega-7 palmitoleic acid
  • Compare with Gotu Kola for wound healing; gotu kola acts through stimulation of collagen synthesis via asiaticoside, a different mechanism from sea buckthorn’s fatty acid-based epithelial support
  • The omega-7 content distinguishes sea buckthorn from all other commonly used medicinal plant oils and represents its unique pharmacological contribution to skin and mucosal health

Related Herbs

Aloe Vera

Aloe barbadensis

C Moderate
Moderate

Aloe vera is paradoxically the most globally popular wound-healing plant yet has the weakest formal European regulatory endorsement among the herbs in this knowledge base. Commission E approved it only for constipation (oral latex); there is no European monograph for topical wound healing. The EMA/HMPC monograph addresses the dried latex laxative use, not the gel for skin. Despite this regulatory gap, clinical evidence -- particularly meta-analyses for burn wound healing -- shows statistically significant benefits (4-9 days faster healing). The evidence is hampered by small, heterogeneous, and often low-quality trials. Aloe vera gel contains acemannan (a glucomannan polysaccharide) as its primary wound-healing compound, which stimulates macrophages, promotes angiogenesis, and increases collagen synthesis.

Read more →

Calendula

Calendula officinalis

C Moderate
Moderate

Calendula is one of the most widely recognized wound-healing herbs in European phytotherapy, with approval from Commission E, ESCOP, and EMA/HMPC. Its anti-inflammatory and wound-healing activity is primarily attributed to triterpenoid faradiol esters. Clinical trial evidence exists but is limited in quality and quantity, with mixed results across wound types. It has an excellent safety profile for topical use.

Read more →

Evening Primrose Oil

Oenothera biennis

C Moderate
Moderate

Evening Primrose Oil is one of the most widely used supplements for women's health, particularly for PMS and cyclical mastalgia. However, there is a notable gap between its consumer popularity and the strength of clinical evidence. The EMA/HMPC has granted only "traditional use" status, and only for dry skin conditions -- not for PMS or mastalgia. The active compound is gamma-linolenic acid (GLA), an omega-6 fatty acid precursor to anti-inflammatory prostaglandins. While some individual trials show positive results for mastalgia and PMS, systematic reviews and meta-analyses present mixed findings. The Cochrane review found insufficient evidence for atopic dermatitis. EPO represents a case where traditional reputation and consumer demand have outpaced scientific validation.

Read more →
esc
↑↓ navigate open esc close